Catalyst Pharmaceuticals Inc (CPRX)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 71 410 | 62 037 | 115 549 | 99 406 | 83 079 | 66 917 | 54 498 | 45 060 |
| Aktywa razem | w tys. USD | 470 114 | 413 211 | 443 896 | 407 227 | 375 630 | 333 114 | 267 309 | 246 972 |
| ROA | 15,19% | 15,01% | 26,03% | 24,41% | 22,12% | 20,09% | 20,39% | 18,24% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $71 410K ÷ $470 114K
= 15,19%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Dynavax Technologies Corp.
DVAX
-0,64%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%